Novo Nordisk A/S

Novo Nordisk A/S is a pharmaceutical company based in Bagsværd, Denmark. Its B shares trade on Nasdaq Copenhagen, while in the US its American depositary receipts (ADRs) trade on the NYSE under the ticker NVO. The price on Lzzo.com is tracked through this ADR. The majority of voting rights in the company belongs to the Novo Nordisk Foundation through Novo Holdings.

Its product range is grouped into two main therapy areas: diabetes treatments, which include insulins and medicines such as Ozempic, whose active ingredient is semaglutide, and obesity treatments offered under the Wegovy brand. The company also develops medicines for rare blood and endocrine disorders such as hemophilia and growth hormone deficiency.

Investors following NVO track competition in the obesity drug market, drug pricing and reimbursement policies in the US, investment in manufacturing capacity and clinical trial results. Lzzo.com offers the Novo Nordisk price in US dollars, a historical chart and technical indicators; the data source and the time of the update are also visible on the page.